Market Quick Take - July 6, 2020

Market Quick Take - July 6, 2020

Macro 3 minutes to read
Steen Jakobsen

Chief Investment Officer

Summary:  Asian stocks, led by Chinese equities, rose overnight following positive comments on the market from Chinese state media. Benchmarks across the region followed while U.S. remain bid, thereby supporting risk appetite across other markets such as crude oil. It highlights the markets ability and willingness to look through rising infection rates towards an anticipated recovery. The dollar trades softer as the euro mount another upside challenge. A thin week in terms of economic news will give the market plenty of time to prepare for the U.S. earnings season, kicking of next week.


What is our trading focus?

  • US500.I (S&P 500 Index) and USNAS100.I (NASDAQ 100 Index) – the S&P 500 is starting the week pushing above the intermediate local highs from 16 June around the 3,156 level which happened during the initial rebound from the sharp selloff on 11 June. This is technically a strong short-term momentum setup for pushing towards the highs from 8 June around 3,231. The Nasdaq 100 pushed briefly beyond 10,500 in early trading continuing its ascent despite record high valuations in the Nasdaq Composite Index.

  • OILUSAUG20 (WTI) OILUKSEP20 (Brent) - both challenging resistance with the continued bid in stocks providing most of the short-term inspiration. The fundamental stalemate between virus related demand worries and OPEC+ production cuts, has driven volatility – using Average True Range (ATR) - down to January levels. Focus this week will be the monthly overview of the worldwide oil market from the IEA on Thursday. EIA’s weekly report on Wednesday will be watched closely for any signs of a renewed slowdown in fuel demand. This as the number of new virus cases rise across the most populous U.S. states. A Brent break above $44/b would likely trigger an attempt to close the gap to $45.18/b.

  • EURUSD - is following crude oil and equities higher this morning setting it up for a test 1.1300 which turned out to be a strong resistance level last week. Comments over the weekend from ECB’s Villeroy that the French recovery looks better than expected is also fueling EUR sentiment.

  • BNK:xpar (European banks) - focus on European banks today after last week’s momentum ending Friday a bit lower and just below the 100-day moving average which was also the key resistance level back at the local highs on 8 June. A firm break above this moving average today could see European banks higher over the week.

What is going on?

  • Asia equities starting the week on a strong note with Chinese equities up 6.7% driven by a bullish front-page editorial in the state-run Chinese Securities Journal extending sentiment off last week’s strong Caixin Services Index reading of 58.4. Retail investors dominating the Chinese equity market are buying the story about the prospects for a healthy bull market. The strong move in Chinese equities seems to be cascading into other markets such as developed equities and crude oil.

  • COVID-19 infections in the US continue rise over the weekend with signs of acceleration in hospitalizations and daily deaths across the Sun Belt risking the reopening of these economies. Other countries such as Japan and Australia have recently seen a resurgence in daily infections and India’s 7-day average daily infections continue to rise.

  • German Factory Orders in May down 29.3% y/y which was worse than expected highlighting the impact from the slowdown in global activity from lockdowns in Q2.

  • Coronavirus related developments have sent two growth dependent commodities in opposite directions. Cocoa has slumped back below $2200/t on worries that the pandemic will weaken chocolate demand at a time when there is expected to be ample supply coming from West Africa. HG copper meanwhile has almost erased the losses for the year, currently trading at $2.75/lb. Strong demand from China supported the rally during the early stages. During the past few weeks however the spreading of the virus has started to impact supplies from the world’s biggest production areas in South America.

What we are watching next?

  • Whether the COVID-19 resurgence extends to hospitalizations and a rise in daily deaths. The US had its worst weekend in terms daily infections with ICU capacity becoming critical in many hotspots across the Sun Belt states such as Arizona, Texas and Florida.

  • ISM Non-Manufacturing for June is published today with expectations looking for 50.0 reading up from 45.4 in May suggest that the services sector in the US is still struggling at much lower activity levels.

  • Q2 earnings season starts next week which will be the most exciting in many years as 80% of S&P 500 companies skipped their guidance in Q1 leaving investors to fly blind into the storm. With US technology stock valuations at record levels there is little margin for error so any revenue miss could lead to steep declines.

  • The market failed to take note of several failed COVID-19 trials last week with both Moderna and Regeneron issuing negative statements. Regeneron and Sanofi said their US Phase 3 trial was not a success against the placebo benchmark and Moderna was rumoured to have seen delays in its study.

  • Corn traders will look towards the World Agriculture Demand & Supply (WASDE) report on July 10 for confirmation that the recent 10% rally can be sustained. Will the smaller than expected planted acreage announced recently be enough to make up for declining demand from ethanol producers thereby helping to keep inventories under control.

Economic Calendar Highlights (times GMT)

  • 14:00 – U.S. ISM Non-manufacturing Index
  • 19:15 – CFTC Commitments of Traders report, delayed release from Friday due to U.S. holiday

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992